Transforming cancer care in Jordan: a 10-year comprehensive patient-centred strategy guided by local experts
Hikmat Abdel‐Razeq(King Hussein Cancer Center), Abdalla Awidi(University of Jordan), Salameh Obeidat(University College Dublin), Laith Al-Showbaki(University of Jordan), Nathir M. Obeidat(University of Jordan), Laila Tutunji(University of Jordan), Majdi H. Aljadayeh(King Hussein Medical Center), Kais Albalbissi(University of Jordan), Asem Mansour(King Hussein Cancer Center), Hanan Jafar(University of Jordan), Yaser Rayyan(University of Jordan), Feras Al-Fararjeh(University of Jordan), Kamal Al-Rabi(King Hussein Cancer Center), Jihad Al Maani(Jordan Hospital), Lubna Hammoudeh(Harvard University)
Cited by 6
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123